EU Pharma Package Deal Explained | Faster Medicines, Innovation & Access | Europe Politics| AT World

The European Parliament held a press conference on 11 December 2025 announcing a provisional agreement on the EU Pharmaceutical Package after overnight negotiations. This landmark reform of EU medicines law aims to improve patient access, boost pharmaceutical innovation, and prevent medicine shortages across Europe.
Key outcomes include new rules on data and market protection for innovative medicines, stronger mechanisms to prevent drug shortages, incentives to tackle antimicrobial resistance through transferable exclusivity vouchers, and faster access to generics and biosimilars via an expanded Bolar exemption.
The agreement also streamlines European Medicines Agency procedures, cutting evaluation timelines and strengthening the role of patients and healthcare professionals. This reform marks one of the most significant updates to EU pharmaceutical regulation in decades.
#EUPharmaPackage
#EuropeanParliament
#EUMedicinesLaw
#HealthcarePolicy
#PharmaceuticalReform
#MedicineAccess
#DrugShortages
#AntimicrobialResistance
#GenericMedicines
#Biosimilars
#EMA
#EUHealth
#PharmaInnovation
#PublicHealth
#EURegulation
-------------------------------------------------
Subscribe to the Amaravati Today, AT World News channel and tap the bell icon to receive notifications whenever we go live
https://www.youtube.com/@atnewsroom

#atworldnews #atworld #AmaravatiToday

Source/Courtesy: EU